GLP1R and prostate carcinoma: The Japanese investigators showed that GLP-1R is expressed in human prostate cancer tissue and exendin-4 (a GLP-1R agonist) significantly decreased the proliferation of prostate cancer cells that expressed GLP-1R [26, 27].